Therapeutic Asset Ratings
278 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
ARX 788
Breast Cancer
QuantumLeap Healthcare Collaborative
P2
CC
(46)
Dan-222
Breast Cancer
QuantumLeap Healthcare Collaborative
P2
CC
(46)
Fianlimab
Breast Cancer
QuantumLeap Healthcare Collaborative
P2
CC
(46)
Gsk 5733584
Breast Cancer
QuantumLeap Healthcare Collaborative
P2
CC
(46)
Immunoglobulin G1, anti-(human neuregulin receptor HER3) (human monoclonal U3-1287 heavy chain), disulfide with human monoclonal U3-1287 ?-chain, dimer
Angiosarcoma
QuantumLeap Healthcare Collaborative
P2
CC
(46)
Immunoglobulin G1, anti-(human neuregulin receptor HER3) (human monoclonal U3-1287 heavy chain), disulfide with human monoclonal U3-1287 ?-chain, dimer
Hormone Receptor Negative Tumor
QuantumLeap Healthcare Collaborative
P2
CC
(46)
Immunoglobulin G1, anti-(human neuregulin receptor HER3) (human monoclonal U3-1287 heavy chain), disulfide with human monoclonal U3-1287 ?-chain, dimer
Hormone Receptor Positive Tumor
QuantumLeap Healthcare Collaborative
P2
CC
(46)
Immunoglobulin G1, anti-(human neuregulin receptor HER3) (human monoclonal U3-1287 heavy chain), disulfide with human monoclonal U3-1287 ?-chain, dimer
Triple-Negative Breast Carcinoma
QuantumLeap Healthcare Collaborative
P2
CC
(46)
IMMUNOGLOBULIN G, ANTI-(HUMAN INSULIN-LIKE GROWTH FACTOR I RECEPTOR) (HUMAN MONOCLONAL HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL LIGHT CHAIN, DIMER
Breast Neoplasm
QuantumLeap Healthcare Collaborative
P2
CC
(46)
N-DESMETHYL-4-HYDROXYTAMOXIFEN
Breast Cancer
QuantumLeap Healthcare Collaborative
P2
CC
(46)
Nelitolimod
Breast Neoplasm
QuantumLeap Healthcare Collaborative
P2
CC
(46)
Nelitolimod
Her2-Receptor Negative Breast Cancer
QuantumLeap Healthcare Collaborative
P2
CC
(46)
Nelitolimod
HER2 Positive Breast Carcinoma
QuantumLeap Healthcare Collaborative
P2
CC
(46)
Sarilumab
Breast Cancer
QuantumLeap Healthcare Collaborative
P2
CC
(46)
vv1
Breast Cancer
QuantumLeap Healthcare Collaborative
P2
CC
(46)
Evorpacept
Neoplasm
QuantumLeap Healthcare Collaborative
P1
CC
(46)
IMMUNOGLOBULIN G, ANTI-(HUMAN INSULIN-LIKE GROWTH FACTOR I RECEPTOR) (HUMAN MONOCLONAL HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL LIGHT CHAIN, DIMER
Her2-Receptor Negative Breast Cancer
QuantumLeap Healthcare Collaborative
P2
CC
(45)
IMMUNOGLOBULIN G, ANTI-(HUMAN INSULIN-LIKE GROWTH FACTOR I RECEPTOR) (HUMAN MONOCLONAL HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL LIGHT CHAIN, DIMER
HER2 Positive Breast Carcinoma
QuantumLeap Healthcare Collaborative
P2
CC
(45)
Immunoglobulin G1, anti-(human neuregulin receptor HER3) (human monoclonal U3-1287 heavy chain), disulfide with human monoclonal U3-1287 ?-chain, dimer
Breast Neoplasm
QuantumLeap Healthcare Collaborative
P2
CC
(44)
Immunoglobulin G1, anti-(human neuregulin receptor HER3) (human monoclonal U3-1287 heavy chain), disulfide with human monoclonal U3-1287 ?-chain, dimer
Her2-Receptor Negative Breast Cancer
QuantumLeap Healthcare Collaborative
P2
CC
(44)
Immunoglobulin G1, anti-(human neuregulin receptor HER3) (human monoclonal U3-1287 heavy chain), disulfide with human monoclonal U3-1287 ?-chain, dimer
HER2 Positive Breast Carcinoma
QuantumLeap Healthcare Collaborative
P2
CC
(44)
Nelitolimod
Breast Cancer
QuantumLeap Healthcare Collaborative
P2
CC
(44)
Evorpacept
Estrogen-Receptor Positive Breast Cancer
QuantumLeap Healthcare Collaborative
P1
CC
(43)
Evorpacept
Estrogen Receptor Positive Tumor
QuantumLeap Healthcare Collaborative
P1
CC
(43)
Evorpacept
HER2 Low Breast Carcinoma
QuantumLeap Healthcare Collaborative
P1
CC
(43)
Showing 201 to 225 of 278 assets
Previous
Page 9 of 12
Next
